BRIDGETTE DEFRANCE: Open Payments
NPI 1801341821 · WESTLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 51 payments from 10 companies in 2025. Trend: 2023 $350 · 2024 $643 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $314 |
| AstraZeneca Pharmaceuticals LP | 10 | $257 |
| GlaxoSmithKline, LLC. | 10 | $136 |
| PFIZER INC. | 4 | $79 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $74 |
| Amgen Inc. | 4 | $69 |
| ABBVIE INC. | 3 | $58 |
| Exact Sciences Corporation | 2 | $39 |
| Gilead Sciences, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: Ozempic, AIRSUPRA, TRELEGY ELLIPTA, JOURNAVX, Rybelsus, PREVNAR 20, QULIPTA, Wegovy.
Industry payments across MI — which companies pay providers there.
